Top Markets
Coin of the day
Scandion Oncology A/S Scandion Oncology A/S

Scandion Oncology A/S

SCOL
Classement en actions #40630
Operating as a clinical-stage biotechnology company, Scandion Oncology A/S... Operating as a clinical-stage biotechnology company, Scandion Oncology A/S specializes in creating pharmaceutical solutions to combat resistance to chemotherapy. Their primary investigational drug, SCO-101, an orally administered compound, is currently progressing through Phase Ib and Phase II clinical studies with cancer patients. Another pipeline candidate, SCO-201, is undergoing preclinical assessment for its potential efficacy against solid tumors. Established in 2017, Scandion Oncology A/S maintains its headquarters in Copenhagen, Denmark.
Prix de l'action
$0.00045794
Dernière synchronisation: 2025-07-11
Capitalisation boursière
$107.51K
Changement (1 jour)
-36.01%
Changement (1 an)
0.00%
Pays
DK
Échange Scandion Oncology A/S (SCOL)

Catégorie

Historique du prix de l'action pour Scandion Oncology A/S (SCOL)
Prix de clôture le plus élevé : $0.00 le 2025-07-01

Prix de clôture le plus bas : $0.74 le 2018-11-01
Historique du prix de l'action de Scandion Oncology A/S de 2018 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 -92.13%
2024 -96.87%
2023 -14.41%
2022 -80.44%
2021 -42.28%
2020 127.83%
2019 80.43%
2018 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$518.36 30.92%
US
$859.40 32.91%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE